Global Cardiac AI Monitoring and Diagnostics Market, By Device Type (ECG Monitor, Event Recorder, Implantable Cardiac Loop Recorder, Pacemaker, Defibrillator, Cardiac Resynchronization Therapy (CRT) Devices, Smart Wearable, Others), End-User (Hospitals and Clinics, Home Care Settings, Others) – Industry Trends and Forecast to 2031.
Cardiac AI Monitoring and Diagnostics Market Analysis and Size
As per the recent data, approximately 6.2 million adults over the age of 20 are newly diagnosed with heart failure. The incidence of heart failure increases with age, and it is more common among older adults. Heart failure is a leading cause of hospitalization among people aged 65 and older. The incidence rates can vary by race and ethnicity, with some groups having a higher risk of developing heart failure.
Data Bridge Market Research analyzes that the global cardiac AI monitoring and diagnostics market which was USD 1,212.62 million in 2023, is likely to reach up to USD 6,170.36 million by 2031, and is expected to undergo a CAGR of 22.8 % during the forecast period. “ECG monitor” dominates the device type segment of the market due to a non-invasive and painless diagnostic technique that has real-time monitoring capability, generates standardized and structured data and seamlessly integrates with wearable devices to the growing demand for better methods for treatment in patients. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, and Pricing in USD
|
|
Segments Covered
|
By Device Type (ECG Monitor, Event Recorder, Implantable Cardiac Loop Recorder, Pacemaker, Defibrillator, Cardiac Resynchronization Therapy (CRT) Devices, Smart Wearable, Others), End-User (Hospitals and Clinics, Home Care Settings, Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East & Africa
|
|
Market Players Covered
|
Koninklijke Philips N.V. (Netherlands), HeartVista Inc. (U.S.), Siemens Healthineers AG (Germany), RSIP Vision (Israel), Ultromics Limited. (U.S.), Tempus Labs Inc. (U.S.), Cardiologs Technologies (U.S.), Cleerly, Inc. (U.S.), AliveCor, Inc. (U.S.), Aidoc Medical Ltd. (Israel), Boston Scientific Corporation (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Cardiac AI monitoring and diagnostics encompasses AI applications and tools designed to analyze diverse cardiac data sources, including medical imaging, electrocardiograms, and wearable device data, to provide precise insights into cardiovascular health. Integral components involve the development of AI algorithms for the detection and interpretation of cardiac anomalies, as well as the seamless integration of these solutions into existing healthcare systems.
Global Cardiac AI Monitoring and Diagnostics Market Dynamics
Drivers
- Increasing Incidence of Cardiovascular Diseases
Cardiovascular diseases, including heart attacks and heart failure, are leading causes of morbidity and mortality globally. AI-based monitoring and diagnostics systems offer the potential to enhance early detection, risk stratification, and management of cardiovascular conditions. These technologies can analyze large datasets, including medical imaging and patient health records, to identify patterns and markers associated with cardiac diseases.
- Advancements in Artificial Intelligence and Machine Learning Technologies
AI algorithms can analyze complex cardiac data, such as electrocardiograms (ECGs), cardiac imaging, and wearable device data, with increased speed and accuracy. Machine learning algorithms have the ability to learn from diverse datasets, enabling more accurate predictions and personalized insights. The continuous improvement and refinement of these AI-based technologies contribute to their adoption in the cardiac diagnostics market.
Opportunities
- Remote Patient Monitoring and Telehealth Integration
The advancement of wearable devices and mobile health technologies allows for continuous monitoring of cardiac parameters outside traditional healthcare settings. AI algorithms can analyze real-time data from wearables and remote monitoring devices, providing healthcare professionals with valuable insights into a patient's cardiac health. This opportunity aligns with the growing demand for telehealth solutions and the desire to extend cardiovascular care beyond hospital walls.
- Personalized Medicine and Treatment Optimization
AI algorithms can analyze diverse datasets, including genetic information, medical imaging, and patient histories, to tailor cardiac treatment plans based on individual characteristics and risk profiles. The ability of AI to identify subtle patterns and associations in large datasets enables more precise risk stratification and treatment recommendations. Personalized medicine in cardiac care can lead to more effective interventions, improved patient outcomes, and a reduction in adverse events.
Restraints/Challenges
- Data Security and Privacy Concerns
The confidentiality and security of health data, particularly in the context of cardiac monitoring and diagnostics, are significant concerns due to its sensitive nature. With the analysis of extensive patient data, encompassing medical records, diagnostic images, and continuous monitoring information, there is an imperative to ensure the utmost privacy and security.
This heightened sensitivity is driven by the growing awareness among healthcare providers, patients, and regulatory bodies regarding the risks associated with data breaches and unauthorized access to health information.
- Integration Complexity with Existing Healthcare Systems
Integrating AI into established healthcare systems poses challenges due to interoperability issues, data format compatibility, and adherence to data exchange standards. Harmonious integration without disrupting clinical workflows is complex. Healthcare providers may struggle with adopting AI, especially when integrating into diverse platforms and electronic health record systems.
This cardiac AI monitoring and diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cardiac AI monitoring and diagnostics market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In August 2023, Koninklijke Philips N.V. integrates Al in cardiac ultrasound and across cardiac care at ESC 2023. Philips is a global leader in health technology, it integrates Al in cardiac ultrasound across cardiac care to help improve clinical confidence and increase efficiency
- In March 2023, Aidoc, the prominent provider of healthcare Al solutions, made a significant breakthrough with the introduction of their groundbreaking cardiovascular Al solutions package
Global Cardiac AI Monitoring and Diagnostics Market Scope
The cardiac AI monitoring and diagnostics market is segmented on the basis of device type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Device Type
- ECG Monitor
- Event Recorder
- Implantable Cardiac Loop Recorder
- Pacemaker
- Defibrillator
- Cardiac Resynchronization Therapy (CRT) Devices
- Smart Wearable
- Others
End User
- Hospitals and Clinics
- Home Care Settings
- Others
Global Cardiac AI Monitoring and Diagnostics Market Regional Analysis/Insights
The cardiac AI monitoring and diagnostics market is analyzed and market size insights and trends are provided by country, device type and end user as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and rest of Middle East & Africa.
North America is expected to dominate the market due to the strong base of healthcare facilities, the strong presence of major players in the market, the extraordinary healthcare infrastructure, and the large pool of people having specifically cardiac disorders.
Asia-Pacific is expected to witness significant growth during the forecast period due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for diagnosis and treatment procedures, the large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The cardiac AI monitoring and diagnostics market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the cardiac AI monitoring and diagnostics market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the cardiac AI monitoring and diagnostics market.
Competitive Landscape and Cardiac AI Monitoring and Diagnostics Market Share Analysis
The cardiac AI monitoring and diagnostics market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the cardiac AI monitoring and diagnostics market.
some of the major players operating in the cardiac AI monitoring and diagnostics market are:
- Koninklijke Philips N.V. (Netherlands)
- HeartVista Inc. (U.S.)
- Siemens Healthineers AG (Germany)
- RSIP Vision (Israel)
- Ultromics Limited. (U.S.)
- Tempus Labs Inc. (U.S.)
- Cardiologs Technologies (U.S.)
- Cleerly, Inc. (U.S.)
- AliveCor, Inc. (U.S.)
- Aidoc Medical Ltd. (Israel)
- Boston Scientific Corporation (U.S.)
SKU-